Sasha Stanton, MD, PhD, is a breast cancer physician-scientist dedicated to developing a DCIS vaccine.Read More
This month is Breast Cancer Awareness Month, a type of cancer against which we have made much progress. However, a recent report from the Centers for Disease Control and Prevention (CDC) highlights that the progress we are making has not been uniform for all segments of the population.Read More
As the temperature soared this summer, the laps around the park became harder to endure.
When her skin chafed from radiation, her doctor told her to take it easy.
Still, Tanya Hall …
Josette Northcott, PhD, is exploring the role that blood vessels play in the growth of tumors and the delivery of chemotherapy.Read More
Guest Post by Virginia Kaklamani, MD, DSc
Co-director of the San Antonio Breast Cancer Symposium (SABCS)
Sara Hanna Velarde, PhD, began her career in cancer research as a graduate student at the University of North Carolina in Chapel Hill (UNC), where she focused on melanoma, an …Read More
It’s that time of year when we reflect on the progress we made over the past 12 months – and in the world of cancer research, that progress has been …Read More
On Nov. 16, 2015, the AACR hosted several dozen patient advocates and executives from leading pharmaceutical companies, as well as several cancer survivors who have participated in the Scientist↔Survivor Program.Read More
Breast cancer researchers are packed up in San Antonio, eager to build on the latest information they gathered at the symposium and to pursue next steps in their efforts to improve patients’ lives.Read More
Breast cancer recurrence rates were similar for postmenopausal women with estrogen receptor-positive DCIS whether they took anastrozole or tamoxifen, but side effects were not.Read More